CLINICAL RELEVANCE OF HISTOPATHOLOGICAL SUBCLASSIFICATION OF DIFFUSE HISTIOCYTIC LYMPHOMA

被引：167

作者：

STRAUCHEN, JA

YOUNG, RC

DEVITA, VT

ANDERSON, T

FANTONE, JC

BERARD, CW

机构：

[1] NCI,DIV CANC BIOL,PATHOL LAB,BETHESDA,MD 20014

[2] NCI,DIV CANC TREATMENT,MED BRANCH,BETHESDA,MD 20014

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1978年 / 299卷 / 25期

关键词：

D O I：

10.1056/NEJM197812212992503

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1382 / 1387

页数：6

共 15 条

[1]

BERARD CW, 1977, CANCER TREAT REP, V61, P1037

[2]

BERARD CW, 1978, CANCER-AM CANCER SOC, V42, P911, DOI 10.1002/1097-0142(197808)42:2+<911::AID-CNCR2820420713>3.0.CO

[3]

2-G

[4]

BRAYLAN RC, 1975, PATHOL ANNU, P213

[5]

DEVITA VT, 1975, LANCET, V1, P248

[6] PROGNOSTIC FACTORS FOR ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA FOLLOWING TREATMENT WITH COMBINATION CHEMOTHERAPY [J].

FISHER, RI ;

DEVITA, VT ;

JOHNSON, BL ;

SIMON, R ;

YOUNG, RC .

AMERICAN JOURNAL OF MEDICINE, 1977, 63 (02) :177-182

[7]

JAFFE ES, 1977, CANCER TREAT REP, V61, P953

[8] NODULAR LYMPHOMA - EVIDENCE FOR ORIGIN FROM FOLLICULAR-B LYMPHOCYTES [J].

JAFFE, ES ;

SHEVACH, EM ;

FRANK, MM ;

BERARD, CW ;

GREEN, I .

NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (15) :813-819

[9]

LUKES RJ, 1974, CANCER, V34, P1488, DOI 10.1002/1097-0142(197410)34:8+<1488::AID-CNCR2820340822>3.0.CO

[10]

2-C

← 1 2 →